- Home
- SRRK vs SNDR Comparison
SRRK vs SNDR Comparison
Compare SRRK & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRRK | SNDR |
|---|---|---|
| Founded | 2012 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.7B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SRRK | SNDR |
|---|---|---|
| Price | $49.84 | $28.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $55.64 | $27.77 |
| AVG Volume (30 Days) | ★ 1.7M | 842.8K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $5,674,300,000.00 |
| Revenue This Year | N/A | $5.14 |
| Revenue Next Year | $544.77 | $6.49 |
| P/E Ratio | ★ N/A | $47.46 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $27.07 | $20.11 |
| 52 Week High | $51.63 | $30.98 |
Technical Indicators
Market Signals| Indicator | SRRK | SNDR |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 61.65 |
| Support Level | $41.07 | $27.69 |
| Resistance Level | N/A | $28.60 |
| Average True Range (ATR) | 2.21 | 0.81 |
| MACD | 0.51 | 0.40 |
| Stochastic Oscillator | 82.19 | 77.98 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.